2025-05-16 - Analysis Report
Okay, here's an analysis of Eli Lilly and Co (LLY), based on the provided data, formatted for readability.

**Report on Eli Lilly and Co (LLY)**

**1. Performance Overview vs. S&P 500 (VOO)**

*   **Ticker:** LLY
*   **Company Description:** Eli Lilly and Co is a global pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products.

**Key Metrics:**

*   **LLY Cumulative Return:** 241.50%
*   **VOO Cumulative Return:** 81.82%
*   **Absolute Spread (LLY - VOO):** 159.7
*   **Spread Range:** Max: 312.7, Min: -27.7
*   **Relative Spread:** 55.1 (Indicates the current spread is in the 55.1th percentile of its historical range.)

**Analysis:** LLY has significantly outperformed the S&P 500 (VOO). The current spread is positive and relatively high, suggesting strong relative performance.  The relative spread of 55.1 indicates the outperformance is above average compared to its historical range.

**Alpha and Beta Analysis**

| Year       | CAGR     | MDD   | Alpha   | Beta  | Cap(B) |
|------------|----------|-------|---------|-------|--------|
| 2015-2017  | 10.0%    | 55.6% | -19.0%  | 0.1   | 67.8   |
| 2016-2018  | 38.0%    | 58.6% | 20.0%   | -0.1  | 95.2   |
| 2017-2019  | 49.0%    | 58.6% | 19.0%   | 0.3   | 110.6  |
| 2018-2020  | 51.0%    | 58.6% | 25.0%   | 0.2   | 144.9  |
| 2019-2021  | 105.0%   | 60.7% | 50.0%   | 0.3   | 240.6  |
| 2020-2022  | 100.0%   | 65.0% | 94.0%   | 0.3   | 323.1  |
| 2021-2023  | 138.0%   | 65.0% | 122.0%  | 0.3   | 519.9  |
| 2022-2024  | 156.0%   | 72.1% | 139.0%  | 0.3   | 693.0  |
| 2023-2025  | 91.0%    | 76.9% | 62.0%   | 0.2   | 647.1  |

**Analysis:**

*   **CAGR:**  The Compounded Annual Growth Rate is very strong in recent periods, peaking in 2022-2024.
*   **MDD:** Maximum Drawdown has been increasing, suggesting increasing volatility/risk.
*   **Alpha:**  Alpha is consistently positive and high, indicating LLY is generating returns independent of the market.  Alpha has shown significant growth recently.
*   **Beta:** Beta is generally low (around 0.2-0.3), indicating LLY is less volatile than the overall market.

**2. Recent Price Action**

*   **Current Price:** 719.63
*   **Last Market Data:** Price: 720.295, Previous Close: 715.56, Change: 0.66
*   **5-Day Moving Average:** 747.588
*   **20-Day Moving Average:** 808.2485
*   **60-Day Moving Average:** 825.7382

**Analysis:** The price is below all three moving averages (5-day, 20-day, and 60-day). This indicates a short-term downtrend. The last market data shows a slight positive change, but the overall trend is downward based on moving averages.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.35018 (Low Risk)
*   **RSI:** 35.07 (Approaching oversold territory)
*   **PPO:** -1.52 (Negative, indicating a downtrend)
*   **20-Day Relative Spread Change:** -4.9 (Short-term decline)
*   **Expected Return:** 124.1% (Long-term, relative to S&P 500)

**Analysis:**

*   The low MRI suggests the overall market risk is low.
*   The RSI is approaching the oversold territory, suggesting a potential for a short-term bounce.
*   The negative PPO confirms the recent downtrend.
*   The negative change in the relative spread (-4.9) further supports the short-term decline.
*   The high Expected Return suggests analysts are very positive about the long-term outlook for LLY.
*   The slightly positive change in the last market data suggests the recent movement may be affected by some other factors.

**4. Recent News & Significant Events**

*   **2025-05-12:** Major business developments, regulatory changes, or market events.
*   **2025-05-16:** Analyst discussions about performance and outlook.
*   **2025-05-14:** Notable stock volatility influenced by recent news.
*   **2025-05-13:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news indicates a period of volatility and significant events influencing the stock. Investors should monitor news and company announcements closely.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2025-05-01 | 3.07 | 12.73 B$      |
| 2024-10-30 | 1.08 | 11.44 B$      |
| 2024-08-08 | 3.29 | 11.30 B$      |
| 2024-04-30 | 2.49 | 8.77 B$       |
| 2025-05-01 | 2.49 | 8.77 B$       |

**Analysis:**

*   Earnings per share (EPS) and revenue have been generally increasing, but there may be duplicated data. Please make sure the data is correct. The most recent EPS and Revenue numbers are strong.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-03-31   | $12.73B    | 82.53%        |
| 2024-12-31   | $13.53B    | 82.24%        |
| 2024-09-30   | $11.44B    | 81.02%        |
| 2024-06-30   | $11.30B    | 80.80%        |
| 2024-03-31   | $8.77B     | 80.91%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE       |
|--------------|-------------|-----------|
| 2025-03-31   | $15.76B     | 17.50%    |
| 2024-12-31   | $14.19B     | 31.07%    |
| 2024-09-30   | $14.24B     | 6.81%     |
| 2024-06-30   | $13.56B     | 21.88%    |
| 2024-03-31   | $12.81B     | 17.51%    |

**Analysis:**

*   **Revenue:** Revenue has generally been increasing, indicating strong sales performance.
*   **Profit Margin:** Profit margins are very high and stable, suggesting efficient operations and strong pricing power.
*   **Equity:** Equity has been growing, reflecting the company's increasing net worth.
*   **ROE:** Return on Equity is volatile, but generally positive, reflecting good profitability relative to equity.

**7. Overall Analysis and Summary**

Eli Lilly and Co (LLY) exhibits a strong long-term growth profile, significantly outperforming the S&P 500.  Financial performance is robust, with high profit margins and growing revenue. Recent news suggests some volatility. The current stock price is experiencing a short-term downtrend, as indicated by moving averages and technical indicators. However, the long-term expected return remains highly positive. Investors should closely monitor news and be aware of the current short-term weakness while considering the strong long-term potential. The recent short-term movement may be affected by some external events.
